• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成釉细胞瘤中 PTHrP 和 RANKL 的表达。

Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Hunan Provincial Key Lab, Otolaryngology Institute of Major Diseases, The Xiangya Hospital, Central South University, Changsha, Hunan, China.

Department of Otolaryngology-Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

出版信息

Acta Otolaryngol. 2020 May;140(5):351-355. doi: 10.1080/00016489.2020.1717609. Epub 2020 Feb 28.

DOI:10.1080/00016489.2020.1717609
PMID:32108533
Abstract

Regarded as the most important clinical characteristic of middle ear cholesteatoma, the exact mechanism of bone resorption in cholesteatoma still remains unknown. To investigate protein expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium and analyze their functional roles in the etiopathogenesis of bone resorption in middle ear cholesteatoma. A total of 22 patients who underwent surgical treatment for middle ear cholesteatoma were recruited in the study. Protein expression of PTHrP and RANKL in middle ear cholesteatoma and normal postauricular skin was investigated by immunohistochemical staining. Correlations between bone resorption degree and expression of PTHrP and RANKL were also analyzed. Protein expression of PTHrP and RANKL in cholesteatoma epithelium significantly increased when compared with normal postauricular skin epithelium. In cholesteatoma epithelium, a significantly positive association was observed between PTHrP and RANKL expression. Meanwhile, obviously positive correlations between protein expression of PTHrP and RANKL and bone resorption degree were discovered. The increased protein expression of PTHrP and RANKL in cholesteatoma epithelium, and their associations with the degree of bone resorption, revealing that PTHrP might promote bone resorption process in middle ear cholesteatoma through RANKL signaling pathway.

摘要

被认为是中耳胆脂瘤最重要的临床特征,胆脂瘤中确切的骨质吸收机制仍不清楚。本研究旨在探讨甲状旁腺激素相关蛋白(PTHrP)和核因子-κB 受体活化因子配体(RANKL)在获得性中耳胆脂瘤上皮中的蛋白表达,并分析它们在中耳胆脂瘤骨质吸收发病机制中的功能作用。共招募 22 例接受中耳胆脂瘤手术治疗的患者作为研究对象。采用免疫组织化学染色法检测中耳胆脂瘤和正常耳后皮肤中 PTHrP 和 RANKL 的蛋白表达,并分析骨吸收程度与 PTHrP 和 RANKL 表达的相关性。与正常耳后皮肤上皮相比,胆脂瘤上皮中 PTHrP 和 RANKL 的蛋白表达明显增加。在胆脂瘤上皮中,PTHrP 和 RANKL 的表达呈显著正相关。同时,还发现 PTHrP 和 RANKL 的蛋白表达与骨吸收程度之间存在明显的正相关。胆脂瘤上皮中 PTHrP 和 RANKL 的蛋白表达增加,且与骨吸收程度相关,表明 PTHrP 可能通过 RANKL 信号通路促进中耳胆脂瘤中的骨吸收过程。

相似文献

1
Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.成釉细胞瘤中 PTHrP 和 RANKL 的表达。
Acta Otolaryngol. 2020 May;140(5):351-355. doi: 10.1080/00016489.2020.1717609. Epub 2020 Feb 28.
2
PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.甲状旁腺激素相关蛋白通过促进破骨细胞分化诱导因子 RANKL 促进中耳胆脂瘤骨破坏。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):655-666. doi: 10.11817/j.issn.1672-7347.2024.230482.
3
HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.HB-EGF表达作为获得性中耳胆脂瘤的潜在生物标志物。
Acta Otolaryngol. 2017 Aug;137(8):797-802. doi: 10.1080/00016489.2017.1284343. Epub 2017 Feb 24.
4
[Molecular control of bone resorption in chronic otitis media with cholesteatoma].[胆脂瘤型慢性中耳炎中骨吸收的分子调控]
Otolaryngol Pol. 2010 Jul-Aug;64(4):219-24. doi: 10.1016/S0030-6657(10)70019-6.
5
Expression of RANKL and OPG in middle ear cholesteatoma tissue.RANKL和OPG在中耳胆脂瘤组织中的表达。
Laryngoscope. 2006 Jul;116(7):1180-4. doi: 10.1097/01.mlg.0000224345.59291.da.
6
Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.酸性 pH 值可能参与中耳胆脂瘤中的骨吸收。
Laryngoscope. 2014 Jan;124(1):245-50. doi: 10.1002/lary.23883. Epub 2013 Oct 1.
7
[The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].[白细胞介素-1α、肿瘤坏死因子-α及甲状旁腺激素相关蛋白在胆脂瘤型中耳炎骨吸收中的作用]
Nihon Jibiinkoka Gakkai Kaiho. 1994 Aug;97(8):1472-80. doi: 10.3950/jibiinkoka.97.1472.
8
Expressions of TRPVs in the cholesteatoma epithelium.胆脂瘤上皮中瞬时受体电位香草酸亚型(TRPVs)的表达。
Acta Otolaryngol. 2017 Oct;137(10):1039-1045. doi: 10.1080/00016489.2017.1336796. Epub 2017 Jun 9.
9
Expression of RANKL and proliferation abilities of cultured human middle ear cholesteatoma epithelial cells.人中耳胆脂瘤上皮细胞培养物中RANKL的表达及增殖能力
Hiroshima J Med Sci. 2013 Mar;62(1):1-6.
10
The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Clin Otolaryngol Allied Sci. 1994 Dec;19(6):516-20. doi: 10.1111/j.1365-2273.1994.tb01280.x.

引用本文的文献

1
PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.甲状旁腺激素相关蛋白通过促进破骨细胞分化诱导因子 RANKL 促进中耳胆脂瘤骨破坏。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):655-666. doi: 10.11817/j.issn.1672-7347.2024.230482.
2
Bone destruction in chronic otitis media is not mediated by the RANKL pathway or estrogen receptor-alpha.慢性中耳炎中的骨质破坏并非由 RANKL 途径或雌激素受体-α介导。
Sci Prog. 2023 Jul-Sep;106(3):368504231199204. doi: 10.1177/00368504231199204.
3
Review of potential medical treatments for middle ear cholesteatoma.
中耳胆脂瘤潜在医学治疗方法的综述。
Cell Commun Signal. 2022 Sep 19;20(1):148. doi: 10.1186/s12964-022-00953-w.